OncoSenX is Drug Discovery in United States that focus on plasmid DNA business. Founded in 2017. They cover business area such as developer, transient gene therapy, cancer, few side effect, apoptosis, plasmid DNA, a novel proteo-lipid vehicle, their transcriptional activity, doctor, medical care professional.
2017
( 7 years old in 2024 )
Plasmid DNA
-
701 Fifth Avenue
Suite 4200
Seattle, WA 98104
United States
Private
developertransient gene therapycancerfew side effectapoptosisplasmid DNAa novel proteo-lipid vehicletheir transcriptional activitydoctormedical care professional
* We use standard office opening hours in near OncoSenX's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OncoSenX is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), OncoSenX business is focusing on Plasmid DNA.
OncoSenX headquarter office and corporate office address is located in 701 Fifth Avenue Suite 4200 Seattle, WA 98104 United States.
OncoSenX was founded in United States.
In 2024, OncoSenX is currently focus on plasmid DNA sector.
Above is snippet of Google Trends for "plasmid DNA" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OncoSenX, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.